?Who binds to it. ? Who binds these inflammatory proteins RAGE SUGAR-FREE GLYCOBIOLOGY INFLAMMATION. BASIC SCIENCE?sugar chain structure

Size: px
Start display at page:

Download "?Who binds to it. ? Who binds these inflammatory proteins RAGE SUGAR-FREE GLYCOBIOLOGY INFLAMMATION. BASIC SCIENCE?sugar chain structure"

Transcription

1 SUGAR-FREE GLYCOBIOLOGY BASIC SCIENCE?sugar chain structure Unusual Sugar Chain It -- is a carboxylate Make lots of It Make an It antibody Inflammatory proteins?who binds to it? Who binds these inflammatory proteins RAGE INFLAMMATION

2 Expansion, homing and activation of CD4CD45RB hi naive T cells CD4CD45RB hi (naïve) Mesenteric lymph nodes Priming and clonal expansion Involves interaction with DCs IL12 CD8/86-CD28 CD4-CD154 CD134L-CD134 Acquire gut homing molecules α4β7, CCR9 Recognized by addressin molecules on vascular endothelium of intestine and home to lamina propria Th1 Lamina Propria CD4-CD154 CD8/86-CD28 CD134L-CD134 leukocyte recruitment from blood and Inflammation Proinflammatory Cytokines TNFα IFNγ IL-12, IL-23 NO MIF macrophages Apoptotic pathways

3 Expansion, homing and activation of CD4CD45RB hi naive T cells CD4CD45RB hi (naïve) Mesenteric lymph nodes Priming and clonal expansion Involves interaction with DCs IL12 CD8/86-CD28 CD4-CD154 CD134L-CD134 Acquire gut homing molecules α4β7, CCR9 Recognized by addressin molecules on vascular endothelium of intestine and home to lamina propria Th1 Lamina Propria CD4-CD154 CD8/86-CD28 CD134L-CD134 leukocyte recruitment from blood and Inflammation Proinflammatory Cytokines TNFα IFNγ IL-12, IL-23 NO MIF macrophages Apoptotic pathways

4 IL-1 pg/ml IL-12 p4 Secretion of cytokines from LPS-activated RAW264.7 murine macrophages 8 4 TNFα ng/1 6 cells IL12p4 pg/ml TNFα IL-1 untreated LPS LPS+GB3.1 LPS+control Ab

5 mabgb3.1 inhibits LPS-induced TNFα and IL23p19 gene expression in murine macrophages TNF α untreated LPS treated LPS + GB3.1 LPS + control Ab.6.5 IL-23p [-LPS] [+LPS] [+LPS/GB3] [+LPS/cAb]

6 % of total cells in unactivated cultures GB3.1 augments cell death of activated macrophages Time after LPS activation (h) -LPS LPS Activated macrophages +LPS +LPS/cAb +LPS/+GB % of total cells in untreated cultures Unactivated macrophages Time of treatment (h)

7 mabgb3.1 inhibits onset of colitis GB3.1 reduces CD4+ T cell accumulation specifically in colon tissues GB3.1 does not induce significant apoptosis of unactivated or activated T-cells GB3.1 inhibited recruitment of monocytes into inflammed areas or caused apoptosis of recruited macrophages No upregulation of MAdCAM expression Proinflammatory cytokine production is reduced Signaling pathways involved?

8 p65 [LPS activation] p65 [IFN/LPS] NF-kappaB p [unactivated] [activated] [activated/gb3.1] [activated/cab]

9 NF-kappaB p65 is enhanced in colon of Crohn s patients Did GB3.1 block NF-κB in treated mice cells? 1.4 NF-kB levels in colonic lamina propria cells cab Tx GB3 Tx Normal p65 RelB mouse #

10 WILL GB3.1 REVERSE COLITIS? early Day 9 Day21 Leithhauser et al Lab Invest 81, 1339, 21

11 Clinical Symptoms Reconstituted, Untreated/cAb treated Loss of weight, loss of hair, soft stools, ill Reconstituted, GB3.1 treated Minimal weight loss, no hair loss, normal stools, healthy

12 Weight loss curves AJ944 (control B) AJ3524 (Control A) AJ2527 (GB3.1) Days post transfer

13 mabgb3.1 treatment reverses colitis in the emerging phase of disease inflammation: proximal colon no cell transfer cell transfer/untreated cell transfer/cab treated Treatment cell transfer/gb3.1 treated

14 mabgb3.1 treatment reverses colitis in the emerging phase of disease inflammation: distal colon no cell transfer cell transfer/untreated cell transfer/cab treated Treatment cell transfer/gb3.1 treated

15 mabgb3.1 treatment reverses colitis in the emerging phase of disease No cell transfer Reconstituted/ untreated Reconstituted/ cab Treated Reconstituted/ mabgb3.1 treated

16 CONCLUSIONS ANTICARBOXYLATE ANTIBODY GB3.1 BLOCKS THE ONSET OF COLITIS THE ANTIBODY ALSO SEEMS TO REVERSES ESTABLISHED COLITIS EFFECTS ARE PROBABLY MEDIATED BY APOPTOSIS OF ACTIVATED MACROPHAGE GB3.1 MAY BE A POTENTIAL TREATMENT FOR IBD In this collaboration between the Freeze and Kronenberg labs Geetha Srikrishna pioneered these studies and contributed most of the data

Faecalibacterium prausnitzii

Faecalibacterium prausnitzii Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients PNAS 105(43): 16731-16736, 2008. Speaker: Ming-Cheng Chen Advisor:

More information

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,

More information

Review Questions: Janeway s Immunobiology 8th Edition by Kenneth Murphy

Review Questions: Janeway s Immunobiology 8th Edition by Kenneth Murphy Review Questions: Janeway s Immunobiology 8th Edition by Kenneth Murphy Chapter 11 (pages 429-460): Dynamics of Adaptive Immunity prepared by Kelly von Elten, Walter Reed National Military Medical Center,

More information

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice Supplementary figure legends Supplementary Figure 1. Characterization of after reconstitution of SCID mice with CD4 + CD62L + T cells. (A-C) SCID mice (n = 6 / group) were reconstituted with 2 x 1 6 CD4

More information

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD Advances in the Pathogenesis of IBD: Genetics Leads to Function Pathogenesis of IBD Environmental Factors Microbes Scott Plevy, MD Associate Professor of Medicine, Microbiology & Immunology UNC School

More information

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012 17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012 The Sagamore Resort, Bolton Landing, NY, USA The following report includes highlights

More information

Chapter 3, Part A (Pages 37-45): Leukocyte Migration into Tissues

Chapter 3, Part A (Pages 37-45): Leukocyte Migration into Tissues Allergy and Immunology Review Corner: Chapter 3, Part A (pages 37-45) of Cellular and Molecular Immunology (Seventh Edition), by Abul K. Abbas, Andrew H. Lichtman and Shiv Pillai. Chapter 3, Part A (Pages

More information

Date of preparation: 06/ IBD/

Date of preparation: 06/ IBD/ Mechanisms Mechanisms of of Disease Disease: The The Science of of IBD IBD 64002 Date of preparation: 06/11 2013 IBD/2013-11-01 Table of Contents IBD Background and Disease Management Etiology and Pathophysiology

More information

LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE

LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE - Small intestine in humans is around 3-4 metres long - Internal surface of the small intestines are lined by villi o Villi are composed of absorptive cells (epithelial/enterocytes)

More information

Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology. Robin Lorenz

Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology. Robin Lorenz Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology Robin Lorenz rlorenz@uab.edu Why do we Need to Understand How the Mucosal Immune System Works? The mucosa is the major

More information

A crucial role for HVEM and BTLA in preventing intestinal inflammation

A crucial role for HVEM and BTLA in preventing intestinal inflammation Washington University School of Medicine Digital Commons@Becker Open Access Publications 2008 A crucial role for HVEM and BTLA in preventing intestinal inflammation Marcos W. Steinberg La Jolla Institute

More information

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s Putting it Together Stephen Canfield smc12@columbia.edu Secondary Lymphoid System Tonsil Anterior Cervical LN s Axillary LN s Mediastinal/Retroperitoneal LN s Thoracic Duct Appendix Spleen Inguinal LN

More information

The Case of the Spring Break Consequences

The Case of the Spring Break Consequences The Case of the Spring Break Consequences Hazel reluctantly opened her eyes when her alarm went off. Spring Break was over, and she was definitely NOT ready for the second half of the semester. However,

More information

Nutrition & Gut Immunity

Nutrition & Gut Immunity Nutrition & Gut Immunity Kenneth A. Kudsk, MD FACS Professor of Surgery University of Wisconsin - Madison Madison, Wisconsin No conflicts of interest to disclose % Survival Survival vs. Malnutrition (after

More information

Supplementary Material

Supplementary Material Supplementary Material Fig. S1. Gpa33 -/- mice do not express Gpa33 mrna or GPA33 protein. (A) The Gpa33 null allele contains a premature translational stop codon (STOP) in exon 2, and almost all of the

More information

T cell maturation. T-cell Maturation. What allows T cell maturation?

T cell maturation. T-cell Maturation. What allows T cell maturation? T-cell Maturation What allows T cell maturation? Direct contact with thymic epithelial cells Influence of thymic hormones Growth factors (cytokines, CSF) T cell maturation T cell progenitor DN DP SP 2ry

More information

Innate immunity as a therapeutic target in IBD. Elke Cario Division of Gastroenterology & Hepatology University Hospital of Essen Essen, Germany

Innate immunity as a therapeutic target in IBD. Elke Cario Division of Gastroenterology & Hepatology University Hospital of Essen Essen, Germany Innate immunity as a therapeutic target in IBD Elke Cario Division of Gastroenterology & Hepatology University Hospital of Essen Essen, Germany The intestinal mucosa must rapidly recognize luminal pathogens

More information

Escherichia coli Nissle 1917

Escherichia coli Nissle 1917 Immunoregulation in Inflammatory Bowel Diseases New therapeutic approaches Probiotics Escherichia coli Nissle 1917 Andreas Sturm Medizinische Klinik m.s. Hepatologie, Gastroenterologie, Endokrinologie

More information

TCR, MHC and coreceptors

TCR, MHC and coreceptors Cooperation In Immune Responses Antigen processing how peptides get into MHC Antigen processing involves the intracellular proteolytic generation of MHC binding proteins Protein antigens may be processed

More information

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes: Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,

More information

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes: Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,

More information

12/10/2009. Department of Pathology, Case Western Reserve University. Mucosal Cytokine Network in IBD

12/10/2009. Department of Pathology, Case Western Reserve University. Mucosal Cytokine Network in IBD Cytokine-Mediated Inflammation in IBD Theresa T. Pizarro Department of Pathology, Case Western Reserve University Mucosal Cytokine Network in IBD Andoh, et al., 2008 1 Interleukin-1 (IL-1) Family Cytokine

More information

Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection

Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection Moriah J. Castleman, Ph.D. Laboratory of Dr. Cara Wilson University of Colorado Anschutz Medical Campus

More information

Lecture 11: Mucosal Immunity (based on lecture by Dr. Betsy Herold, Einstein)

Lecture 11: Mucosal Immunity (based on lecture by Dr. Betsy Herold, Einstein) Lecture 11: Mucosal Immunity (based on lecture by Dr. Betsy Herold, Einstein) Questions to Consider How is the mucusal immune system different from the systemic immune system? How does the immune system

More information

ONLINE SUPPLEMENT MATERIAL. CD70 limits atherosclerosis and promotes macrophage function.

ONLINE SUPPLEMENT MATERIAL. CD70 limits atherosclerosis and promotes macrophage function. ONLINE SUPPLEMENT MATERIAL CD7 limits atherosclerosis and promotes macrophage function. Holger Winkels* 1,2, Svenja Meiler* 1,2, Esther Smeets* 2, Dirk Lievens 1, David Engel 3, Charlotte Spitz 1, Christina

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:1.138/nature1554 a TNF-α + in CD4 + cells [%] 1 GF SPF 6 b IL-1 + in CD4 + cells [%] 5 4 3 2 1 Supplementary Figure 1. Effect of microbiota on cytokine profiles of T cells in GALT. Frequencies of TNF-α

More information

Innate immune cells---- one time migration preprogrammed homing properties

Innate immune cells---- one time migration preprogrammed homing properties Innate immune cells---- one time migration preprogrammed homing properties neutrophils---acute inflammation monocytes---subacute/chronic inflammation eosinophils---parasitic or allergic inflammation natural

More information

Innate Immunity II. Integration. Lindsay Nicholson Advanced Immunology L2

Innate Immunity II. Integration. Lindsay Nicholson Advanced Immunology L2 Innate Immunity II Integration Lindsay Nicholson Advanced Immunology L2 l.nicholson@bristol.ac.uk Lecture 1 Defining Innate Immunity Recognition and effector mechanisms (I) Lecture 2 Recognition and effector

More information

Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was

Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was sorted by FACS. Surface markers for sorting were CD11c +

More information

Immune response to infection

Immune response to infection Immune response to infection Dr. Sandra Nitsche (Sandra.Nitsche@rub.de ) 20.06.2018 1 Course of acute infection Typical acute infection that is cleared by an adaptive immune reaction 1. invasion of pathogen

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10134 Supplementary Figure 1. Anti-inflammatory activity of sfc. a, Autoantibody immune complexes crosslink activating Fc receptors, promoting activation of macrophages, and WWW.NATURE.COM/NATURE

More information

The Immune Response in Time and Space

The Immune Response in Time and Space The Immune Response in Time and Space Chapters 14 & 4 Sharon S. Evans, Ph.D. Department of Immunology 845-3421 sharon.evans@roswellpark.org September 18 & 23, 2014 Inflammation Inflammation Complex response

More information

FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH

FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH ALETA A SOURCE OF 1,3-BETA GLUCANS Aleta is highly bioavailable, offering a concentration greater than 5% of 1,3-beta glucans. Aleta provides a consistent response

More information

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany IL-12 family members in experimental colitis Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany IBD - Pathogenesis Genetic Predisposition Bacterial Antigens Activation of

More information

Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES

Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES Natasa Strbo M.D. Ph.D. Paris, AIDS Vaccine 29 October 19 22 Why is cell secreted gp96 Ig vaccine approach innovative and unconventional?

More information

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes

More information

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier Micro 204 Cytotoxic T Lymphocytes (CTL) Lewis Lanier Lewis.Lanier@ucsf.edu Lymphocyte-mediated Cytotoxicity CD8 + αβ-tcr + T cells CD4 + αβ-tcr + T cells γδ-tcr + T cells Natural Killer cells CD8 + αβ-tcr

More information

Dendritic cells in cancer immunotherapy Aimin Jiang

Dendritic cells in cancer immunotherapy Aimin Jiang Dendritic cells in cancer immunotherapy Aimin Jiang Feb. 11, 2014 Dendritic cells at the interface of innate and adaptive immune responses Dendritic cells: initiators of adaptive immune responses Dendritic

More information

Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides

Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides Research article Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides Stefan Fichtner-Feigl, Ivan J. Fuss, Jan C. Preiss, Warren Strober, and Atsushi Kitani

More information

Adaptive immune responses: T cell-mediated immunity

Adaptive immune responses: T cell-mediated immunity MICR2209 Adaptive immune responses: T cell-mediated immunity Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will discuss the T-cell mediated immune response, how it is activated,

More information

Animal Models to Understand Immunity

Animal Models to Understand Immunity Animal Models to Understand Immunity Hussein El Saghire hesaghir@sckcen.be Innate Adaptive immunity Immunity MAPK and NF-kB TLR pathways receptors Fast Slow Non-specific Specific NOD-like receptors T-cell

More information

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells ICI Basic Immunology course Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells Abul K. Abbas, MD UCSF Stages in the development of T cell responses: induction

More information

Accepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo

Accepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo Accepted Manuscript Innate immune cells regulate oncoimmunity and cancer development Ai-Ping Bai, Yuan Guo PII: S0016-5085(18)34974-6 DOI: 10.1053/j.gastro.2018.08.057 Reference: YGAST 62119 To appear

More information

Immunology, Faculty of Medicine University of Bari, Bari (Italy) Proprietà benefiche di latte, vino e olio extra vergine di oliva

Immunology, Faculty of Medicine University of Bari, Bari (Italy) Proprietà benefiche di latte, vino e olio extra vergine di oliva Immunology, Faculty of Medicine University of Bari, Bari (Italy) Proprietà benefiche di latte, vino e olio extra vergine di oliva Professor Emilio Jirillo basketball court (about 400 m 2 ) mucosa-associated

More information

B cell activation and antibody production. Abul K. Abbas UCSF

B cell activation and antibody production. Abul K. Abbas UCSF 1 B cell activation and antibody production Abul K. Abbas UCSF 2 Lecture outline B cell activation; the role of helper T cells in antibody production Therapeutic targeting of B cells 3 Principles of humoral

More information

New and Future Adhesion Molecule Based Therapies in IBD

New and Future Adhesion Molecule Based Therapies in IBD New and Future Adhesion Molecule Based Therapies in IBD Brian G. Feagan Professor of Medicine, Epidemiology and Biostatistics University of Western Ontario Robarts Clinical Trials London, Ontario, Canada

More information

SUPPLEMENTARY MATERIAL

SUPPLEMENTARY MATERIAL SUPPLEMENTARY MATERIAL IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the T H 17 cell it reg cell balance Rajatava Basu 1,5, Sarah K.

More information

Immunology MIMM-314 MID-TERM II EXAMINATION. 1 hour between 8:30 a.m. - 10:00 a.m. McIntyre Medical Rm 504 (Martin Amphitheatre)

Immunology MIMM-314 MID-TERM II EXAMINATION. 1 hour between 8:30 a.m. - 10:00 a.m. McIntyre Medical Rm 504 (Martin Amphitheatre) GROUP (Version) 1 Annotated version April 8, 2011, RGEP DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY Immunology MIMM-314 MID-TERM II EXAMINATION Course Coordinator: Dr. Roger Palfree Date: Thursday, March

More information

A Novel Class of Living Medicines

A Novel Class of Living Medicines A Novel Class of Living Medicines Synthetic Biotic TM medicines to perform and deliver critical therapeutic functions to treat diseases throughout the body Using Synthetic Biotic Medicines to Activate

More information

Selective leucocyte trafficking inhibitors for treatment of IBD

Selective leucocyte trafficking inhibitors for treatment of IBD Selective leucocyte trafficking inhibitors for treatment of IBD Séverine Vermeire MD, PhD Department of Gastroenterology University Hospitals Leuven Belgium Migration of Leucocytes plays a key role in

More information

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009 T Cell Activation Patricia Fitzgerald-Bocarsly March 18, 2009 Phases of Adaptive Immune Responses Phases of T cell responses IL-2 acts as an autocrine growth factor Fig. 11-11 Clonal Expansion of T cells

More information

Probiotic bacteria: mechanisms of action?

Probiotic bacteria: mechanisms of action? Probiotic bacteria: mechanisms of action? Probiotic derived antibacterial substances (microcins) Competitive inhibition of pathogens Modulation of inflammatory responses: Increasing antiinflammatory cytokine

More information

T Regulatory Cell and Body Tolerance

T Regulatory Cell and Body Tolerance Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2017, 9 [5]:23-28 [http://scholarsresearchlibrary.com/archive.html] ISSN 0975-5071 USA CODEN: DPLEB4

More information

ASH 2011 aktualijos: MSC TPŠL gydyme. Mindaugas Stoškus VULSK HOTC MRMS

ASH 2011 aktualijos: MSC TPŠL gydyme. Mindaugas Stoškus VULSK HOTC MRMS ASH 2011 aktualijos: MSC TPŠL gydyme Mindaugas Stoškus VULSK HOTC MRMS #3042. Yukiyasu Ozawa et al. Mesenchymal Stem Cells As a Treatment for Steroid-Resistant Acute Graft Versus Host Disease (agvhd);

More information

IL-24 AND ITS ROLE IN WOUND HEALING

IL-24 AND ITS ROLE IN WOUND HEALING IL-24 AND ITS ROLE IN WOUND HEALING Nancy J. Poindexter, Ryan Williams, Garth Powis, Sunil Chada, and Elizabeth A. Grimm & Introgen Therapeutics, Inc., Houston, TX IL-24/MDA 24/MDA-77 is a Tumor Suppressor

More information

SUBDIVISIONS OF THE MUCOSA Distinct features of type I and type II mucosal surfaces

SUBDIVISIONS OF THE MUCOSA Distinct features of type I and type II mucosal surfaces Alessandra Pernis P&S 9-435 X53763 abp1@columbia.edu CHALLENGES FACED BY THE MUCOSAL SYSTEM SPECIALIZATION OF CELLS INVOLVED IN MUCOSAL IMMUNITY ORGANIZATION OF THE MUCOSAL IMMUNE SYSTEM CLINICAL IMPLICATIONS

More information

Monocytes must also leave the circulation in response to inflammatory signals, and neutrophils and other granulocytes must be able to do so as well.

Monocytes must also leave the circulation in response to inflammatory signals, and neutrophils and other granulocytes must be able to do so as well. Immunology Dr. John J. Haddad Chapter 15 Leukocyte Migration and inflammation Lymphocytes must recirculate in the body in search of antigens. Since antigens are brought to lymph nodes and the spleen, the

More information

CD40L TCR IL-12 TLR-L

CD40L TCR IL-12 TLR-L CD40L B cells plasmacells Neutrophils TCR inkt cells IL-12 Ab production Can inkt cells modulate the cytokine profile of neutrophils? TLR-L CD4+ and CD8+ T cell responses 1. The invariant TCR expressed

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi: 1.138/nature89 IFN- (ng ml ) 5 4 3 1 Splenocytes NS IFN- (ng ml ) 6 4 Lymph node cells NS Nfkbiz / Nfkbiz / Nfkbiz / Nfkbiz / IL- (ng ml ) 3 1 Splenocytes IL- (ng ml ) 1 8 6 4 *** ** Lymph node cells

More information

Supplementary Figure 1 IL-27 IL

Supplementary Figure 1 IL-27 IL Tim-3 Supplementary Figure 1 Tc0 49.5 0.6 Tc1 63.5 0.84 Un 49.8 0.16 35.5 0.16 10 4 61.2 5.53 10 3 64.5 5.66 10 2 10 1 10 0 31 2.22 10 0 10 1 10 2 10 3 10 4 IL-10 28.2 1.69 IL-27 Supplementary Figure 1.

More information

ROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU. PhD THESIS Summary

ROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU. PhD THESIS Summary ROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU PhD THESIS Summary INVOLVEMENT OF ALARMIN HMGB1 IN INFLAMMATORY PROCESSES ASSOCIATED WITH VASCULAR DYSFUNCTION IN HYPERLIPIDEMIA

More information

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins, Cytokines http://highered.mcgraw-hill.com/sites/0072507470/student_view0/chapter22/animation the_immune_response.html Cytokines modulate the functional activities of individual cells and tissues both under

More information

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline 1 T Lymphocyte Activation and Costimulation Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline T cell activation Costimulation, the B7:CD28 family Inhibitory receptors of T cells Targeting costimulators for

More information

Sharon S. Evans, Ph.D. Dept. Immunology, RPCI Jan. 29 & Feb 3, 2015

Sharon S. Evans, Ph.D. Dept. Immunology, RPCI Jan. 29 & Feb 3, 2015 Adhesion Molecules And Lymphocyte Homing Sharon S. Evans, Ph.D. Dept. Immunology, RPCI Jan. 29 & Feb 3, 2015 Outline General introduction to lymphocyte trafficking homeostatic recirculation vs active recruitment.

More information

Basis of Immunology and

Basis of Immunology and Basis of Immunology and Immunophysiopathology of Infectious Diseases Jointly organized by Institut Pasteur in Ho Chi Minh City and Institut Pasteur with kind support from ANRS & Université Pierre et Marie

More information

Supplementary information CD4 T cells are required for both development and maintenance of disease in a new model of reversible colitis

Supplementary information CD4 T cells are required for both development and maintenance of disease in a new model of reversible colitis Supplementary information CD4 T cells are required for both development and maintenance of disease in a new model of reversible colitis rasseit and Steiner et al. .. Supplementary Figure 1 % of initial

More information

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital New treatment options in UC Rob Bryant IBD Consultant Royal Adelaide Hospital Talk Outline 1. Raising expectations 2. Optimising UC therapy 3. Clinical trials 4. What s new on the PBS? 5. Questions 1.

More information

Follicular Lymphoma. ced3 APOPTOSIS. *In the nematode Caenorhabditis elegans 131 of the organism's 1031 cells die during development.

Follicular Lymphoma. ced3 APOPTOSIS. *In the nematode Caenorhabditis elegans 131 of the organism's 1031 cells die during development. Harvard-MIT Division of Health Sciences and Technology HST.176: Cellular and Molecular Immunology Course Director: Dr. Shiv Pillai Follicular Lymphoma 1. Characterized by t(14:18) translocation 2. Ig heavy

More information

Muramyl dipeptide activation of nucleotidebinding oligomerization domain 2 protects mice from experimental colitis

Muramyl dipeptide activation of nucleotidebinding oligomerization domain 2 protects mice from experimental colitis Research article Muramyl dipeptide activation of nucleotidebinding oligomerization domain 2 protects mice from experimental colitis Tomohiro Watanabe, 1,2 Naoki Asano, 1 Peter J. Murray, 3 Keiko Ozato,

More information

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis Research article Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis Weicheng Liu, 1 Yunzi Chen, 1,2 Maya Aharoni Golan, 1 Maria L. Annunziata, 1 Jie Du, 2 Urszula Dougherty,

More information

Parallel session IVB. Chair: Hans Wildiers

Parallel session IVB. Chair: Hans Wildiers Parallel session IVB Biology of ageing and cancer Chair: Hans Wildiers IMMUNOSENESCENCE AND AGEING Tamas Fulop M.D., PhD Research Center on Aging, Division of Geriatrics, University of Sherbrooke, Sherbrooke,

More information

The T cell receptor for MHC-associated peptide antigens

The T cell receptor for MHC-associated peptide antigens 1 The T cell receptor for MHC-associated peptide antigens T lymphocytes have a dual specificity: they recognize polymporphic residues of self MHC molecules, and they also recognize residues of peptide

More information

Asthma. In Europe ~30 million children and adults under 45 have asthma. On average 3 people a day die from asthma in the UK

Asthma. In Europe ~30 million children and adults under 45 have asthma. On average 3 people a day die from asthma in the UK Dr Neil Williams Nottingham Trent University College of Science and Technology Department of Sport Science Email: neil.williams@ntu.ac.uk @NeilW_ExPhys 1 Asthma In Europe ~30 million children and adults

More information

BUT ONLY MINIMALLY AFFECTS OTHER INDICATORS OF COLONIC INTEGRITY IN A RAT MODEL OF

BUT ONLY MINIMALLY AFFECTS OTHER INDICATORS OF COLONIC INTEGRITY IN A RAT MODEL OF EMU OIL INCREASES CRYPT DEPTH BUT ONLY MINIMALLY AFFECTS OTHER INDICATORS OF COLONIC INTEGRITY IN A RAT MODEL OF COLITIS SUZANNE MASHTOUB Discipline of Physiology, School of Molecular & Biomedical Science,

More information

New treatment options in IBD: today and the future. Silvio Danese Istituto Clinico Humanitas, Milan, Italy

New treatment options in IBD: today and the future. Silvio Danese Istituto Clinico Humanitas, Milan, Italy New treatment options in IBD: today and the future Silvio Danese Istituto Clinico Humanitas, Milan, Italy Date of preparation: October 2014 GLO/EYV/2014-00010h Overview of the late-stage IBD drug pipeline*

More information

Presented by Lucas Nemec. Nat. Med. 21, (2015)

Presented by Lucas Nemec. Nat. Med. 21, (2015) Presented by Lucas Nemec Nat. Med. 21, 647 53 (2015) 1 Introduction Sylvia S. Mader, Inquiry into Life, 8th Edition, 1997 2 Introduction Sylvia S. Mader, Inquiry into Life, 8th Edition, 1997 3 Introduction

More information

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214,

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214, Adaptive Immunity Jeffrey K. Actor, Ph.D. MSB 2.214, 500-5344 Lecture Objectives: Understand role of various molecules including cytokines, chemokines, costimulatory and adhesion molecules in the development

More information

Supplementary Information

Supplementary Information Supplementary Information Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease Sebastian Zeissig, Elisa Rosati, C. Marie Dowds, Konrad

More information

Immune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich

Immune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich Immune Checkpoints PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich Activation of T cells requires co-stimulation Science 3

More information

INFLAMMATORY BOWEL DISEASE (IBD)

INFLAMMATORY BOWEL DISEASE (IBD) RESEARCH OPPORTUNITIES FOR SPECIFIC DISEASES AND DISORDERS Prospects for Research in Inflammatory Bowel Disease Richard S. Blumberg, MD Warren Strober, MD INFLAMMATORY BOWEL DISEASE (IBD) is a chronic

More information

Tolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS

Tolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS 1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails

More information

CHAPTER 9 BIOLOGY OF THE T LYMPHOCYTE

CHAPTER 9 BIOLOGY OF THE T LYMPHOCYTE CHAPTER 9 BIOLOGY OF THE T LYMPHOCYTE Coico, R., Sunshine, G., (2009) Immunology : a short course, 6 th Ed., Wiley-Blackwell 1 CHAPTER 9 : Biology of The T Lymphocytes 1. 2. 3. 4. 5. 6. 7. Introduction

More information

Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence

Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence IL-1α Forward primer 5 -CAAGATGGCCAAAGTTCGTGAC-3' Reverse primer 5 -GTCTCATGAAGTGAGCCATAGC-3 IL-1β

More information

Supplementary Figure 1. H-PGDS deficiency does not affect GI tract functions and anaphylactic reaction. (a) Representative pictures of H&E-stained

Supplementary Figure 1. H-PGDS deficiency does not affect GI tract functions and anaphylactic reaction. (a) Representative pictures of H&E-stained 1 2 3 4 5 6 7 8 9 10 11 Supplementary Figure 1. H-PGDS deficiency does not affect GI tract functions and anaphylactic reaction. (a) Representative pictures of H&E-stained jejunum sections ( 200 magnification;

More information

Intestinal Microbiota in Health and Disease

Intestinal Microbiota in Health and Disease Intestinal Microbiota in Health and Disease February 27, 2015 Master s Course in Gastroenterology Prof. Kathy McCoy 1 Overview Overview of Gut Microbiota Microbiota in Health Microbiota in Disease 2 Gut

More information

Effector T Cells and

Effector T Cells and 1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New

More information

The mouse cholera toxin model for evaluation of allergenicity

The mouse cholera toxin model for evaluation of allergenicity The mouse cholera toxin model for evaluation of allergenicity Joost Smit, ILSI 2012 Of mice and men.(mestas, J Immunol 2004; 172:2731) Mouse Human Neutrophils in blood 10-25% 50-70% Lymphocytes in blood

More information

Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease

Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease Online Submissions: http://www.wjgnet.com/1007-9327office wjg@wjgnet.com doi:10.3748/wjg.v17.i33.3761 World J Gastroenterol 2011 September 7; 17(33): 3761-3775 ISSN 1007-9327 (print) ISSN 2219-2840 (online)

More information

Nonspecific External Barriers skin, mucous membranes

Nonspecific External Barriers skin, mucous membranes Immune system Chapter 36 BI 103 Plant-Animal A&P Levels of Defense Against Disease Nonspecific External Barriers skin, mucous membranes Physical barriers? Brainstorm with a partner If these barriers are

More information

T Cell Effector Mechanisms I: B cell Help & DTH

T Cell Effector Mechanisms I: B cell Help & DTH T Cell Effector Mechanisms I: B cell Help & DTH Ned Braunstein, MD The Major T Cell Subsets p56 lck + T cells γ δ ε ζ ζ p56 lck CD8+ T cells γ δ ε ζ ζ Cα Cβ Vα Vβ CD3 CD8 Cα Cβ Vα Vβ CD3 MHC II peptide

More information

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as

More information

B and T cell Memory. Bengt Lindbom Adap6ve Immunity BMC D14

B and T cell Memory. Bengt Lindbom Adap6ve Immunity BMC D14 B and T cell Memory Bengt Lindbom Adap6ve Immunity BMC D14 Immunity: a historical perspec6ve 430 B.C. Thucydides describes the ongoing plague of Athens:.the same man was never attacked twice 15th century:

More information

TD-BF01: Innate immunity to microorganisms

TD-BF01: Innate immunity to microorganisms TD-BF01: Innate immunity to microorganisms I. Toll receptors (adapted from Takeuchi, O. et al. (1999) Immunity 11:443; Kawai, T. et al. (1999) Immunity 11:115; Hemmi, H. et al. (2000) Nature 408:740; Muzio,

More information

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Robert B. Colvin Transplantation: Friendly organs in a hostile environment Robert B. Colvin,

More information

Therapies for IBD: the Pipeline. New Therapeutic Agents in IBD

Therapies for IBD: the Pipeline. New Therapeutic Agents in IBD Therapies for IBD: the Pipeline New Therapeutic Agents in IBD William J. Sandborn, MD Professor & Chief, Division of Gastroenterology Director, UCSD IBD Center Budesonide Oral MMX budesonide Rectal budesonide

More information

for six pairs of mice. (b) Representative FACS analysis of absolute number of T cells (CD4 + and

for six pairs of mice. (b) Representative FACS analysis of absolute number of T cells (CD4 + and SUPPLEMENTARY DATA Supplementary Figure 1: Peripheral lymphoid organs of SMAR1 -/- mice have an effector memory phenotype. (a) Lymphocytes collected from MLNs and Peyer s patches (PPs) of WT and SMAR1

More information

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel Supplementary Figures 1-8 Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel Marc Schmidt 1,2, Badrinarayanan Raghavan 1,2, Verena Müller 1,2, Thomas Vogl 3, György

More information

News dalla ricerca: identificazione di nuove molecole come target di terapia nelle infiammazioni intestinali

News dalla ricerca: identificazione di nuove molecole come target di terapia nelle infiammazioni intestinali News dalla ricerca: identificazione di nuove molecole come target di terapia nelle infiammazioni intestinali Salvatore Cucchiara, Sapienza Università di Roma Dipartimento di Pediatria e Neuropsichiatria

More information

Oncologist-induced Disease of the GI tract: New Developments

Oncologist-induced Disease of the GI tract: New Developments Oncologist-induced Disease of the GI tract: New Developments Jeffrey D Goldsmith, MD Children s Hospital Boston, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, MA Everyone s on drugs

More information